Stocks · Health care · Biological Products, (No Diagnostic Substances)

Immunovant, Inc.

IMVT Clue Score35

United States Fiscal year ends March CIK 0001764013 Results filed 6 Aug 2026

Add to watchlist

What the insiders did Net buying

Bought (120 mo)

$784.89M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$43.07M

$2.95M on a plan · $8.93M straight out of an exercise

Sold at will

$31.19M

231 of 259 sales

Net

+$741.82M

+$753.70M against sales at will